Clinical Experience with Telavancin: Real-World Results from the Telavancin Observational Use Registry (TOUR™)

• 主要な著者: Adam M. Bressler (著者), Ali A. Hassoun (著者), Louis D. Saravolatz (著者), Valerie Ravenna (著者), Chris N. Barnes (著者), Bibiana Castaneda-Ruiz (著者)
• フォーマット: 図書
• 出版事項: Adis, Springer Healthcare, 2019-11-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Abstract Background Telavancin-a lipoglycopeptide antibacterial agent active against Gram-positive pathogens including methicillin-sensitive and -resistant Staphylococcus aureus (MRSA)-is approved in the USA for once-daily intravenous use. This registry study captured patient characteristics, prescr...